CIK 0001691082 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
LB PHARMACEUTICALS INC
Sign in to watch- Ticker
- LBRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 917-450-6581
- Business address
- 575 MADISON AVENUE, NEW YORK, NY, 10022
- Former names
- LB PHARMACEUTICALS INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-12 | Deep Track Biotechnology Master Fund, Ltd. 10% owner | Purchase | +2,000,000 | $15.00 | $30.0M | 2,686,138 |
| 2025-09-12 | Deep Track Biotechnology Master Fund, Ltd. 10% owner | Purchase | +666,666 | $15.00 | $10.0M | 666,666 |
| 2025-09-12 | Pontifax Management 4 G.P. (2015) Ltd. 10% owner | Purchase | +1,000,000 | $15.00 | $15.0M | 1,411,681 |
| 2025-09-12 | Nussbaum Ran Director | Purchase | +1,000,000 | $15.00 | $15.0M | 1,411,681 |
| 2025-09-12 | Vida Ventures GP III, L.L.C. 10% owner | Purchase | +332,566 | $15.00 | $5.0M | 880,214 |
| 2025-09-12 | Vida Ventures GP III, L.L.C. 10% owner | Purchase | +767 | $15.00 | $12K | 2,029 |
Page 1 of 1 · 6 trades